Merck & Co Inc. (NYSE: MRK), Hologic, Inc. (NASDAQ: HOLX), LivePerson Inc. (NASDAQ: LPSN), Marvell Technology Group (NASDAQ: MRVL), U.S. Auto Parts (NASDAQ: PRTS) and Regeneron Pharma (NASDAQ: REGN) had ratings on them reiterated by analysts.
JPMorgan Chase & Co. (NYSE:JPM) reiterated its "Overweight" rating on Merck & Co Inc. (MRK). They have a price target of $44.00 on the company.
Brean Murray reiterated its "Hold" rating on Hologic, Inc. (HOLX).
Ladenburg Thalmann reiterated its "Buy" rating on LivePerson Inc. (LPSN). They have a price target of $16.00 on the company.
FBR Capital reiterated its "Outperform" rating on Marvell Technology Group (MRVL). They have a price target of $20.00 on the company.
Barrington Research reiterated its "Outperform" rating on U.S. Auto Parts (PRTS).
Deutsche Bank (NYSE:DB) reiterated its "Buy" rating on Regeneron Pharma (REGN). They have a price target of $67.00 on the company.
No comments:
Post a Comment